Fishman Jay A LTD Amgen Inc Transaction History

Fishman Jay A LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $11.2 Million - $12.6 Million	-61,985 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $80,280 - $93,712	-450 Reduced 0.72%	61,985 $12.1 Million
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $296,464 - $334,224	-1,600 Reduced 2.5%	62,435 $0
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $247,367 - $289,080	-1,460 Reduced 2.23%	64,035 $0
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $10,127 - $11,315	60 Added 0.09%	65,495 $0
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $10.9 Million - $12.5 Million	65,435	65,435 $0

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

Stay updated on Fishman Jay A LTD with notifications on news.